Here are relevant reports on : central-nervous-system-drug-delivery-market
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone) PCL), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2029
The bioresorbable polymers market is expected to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6% during the forecast period. The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Laboratory Information System (LIS) Market by Product (Standalone, Integrated), Component (Services, Software), Delivery Mode (On-premise & Cloud-based), End User (Hospital Laboratories, Independent Laboratories, POLs) and Region - Global Forecast to 2028
The global laboratory information system market, valued at US$2.0 billion in 2022, stood at US$2.4 billion in 2023 and is projected to advance at a resilient CAGR of 10.8% from 2023 to 2028, culminating in a forecasted valuation of US$4.0 billion by the end of the period. The expansion of molecular diagnostic techniques, including genomics and personalized medicine, and the need for automation and robotics in laboratories primarily drive the market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Emergency Department Information System Market by Delivery Mode (On-Premise, Software as a Service), Software Type (Best-Of-Breed, Enterprise Solutions), Application (CPOE, Patient Tracking & Triage), End User – Global Forecast to 2019
The global emergency department information system (EDIS) market was valued at $312.68 million in 2014 and poised to grow at a CAGR of 15.24% between 2012 and 2019, to reach $635.50 million in 2019. The rapid increase in healthcare expenditure, increasing use of data-driven technologies, implementation of the HITECH Act, and rise in aging population will be the most important growth drivers for this market in the forecast period (2012–2019).
- Published: November 2014
- Price: $ 4950
- TOC Available:
-
Portable Oxygen Concentrators Market by Delivery System (Continuous Flow, Pulse Dose), Application (COPD, Asthma, Respiratory Distress Syndrome), and End User (Hospitals, Home Care Settings) - Global Forecast to 2023
The global portable oxygen concentrator (POC) market is expected to reach USD 346.8 million in 2023 from USD 204.9 million in 2018, growing at a CAGR of 11.1%. Increasing prevalence of COPD, Asthma, respiratory distress syndrome, and other respiratory disease are the major driving factors for this market. In addition to this, increasing geriatric population also support the growth of this market to a certain extent. Moreover, shift from traditional cylinders to portable oxygen concentrator fuel the demand for portable oxygen concentrators during forecast period. On the other hand, increasing focus of players on emerging market also expected to increase the demand for POC during forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Operation & Business Support System Market by OSS Solutions (Network Planning & Design, Service Delivery), BSS Solutions (Product/Service Management, Customer Management, Revenue Management), End-Users and by Geography - Analysis & Forecasts to 2020
Operation support system (OSS) & business support systems (BSS) are processes that support the back office activity as well as the activities that take place while interacting with the customers over the network. OSS is liable for managing faults in the network, configuration of networks, and security and service assurance. BSS is accountable for managing rating, billing, revenue assurance, business intelligence, product management, fraud management, and customer management. MarketsandMarkets expects the global OSS/BSS market to grow from USD 23.95 Billion in 2015 to USD 42.81 Billion by 2020, at a CAGR of 12.3 %. The key driver of OSS/BSS market is the cost-effective business process to gain competitive edge in the industry.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Home Healthcare Software - Product & Service Market - Application (Clinical, Non - Clinical), Usage (Laptop, Smartphone), Product (Agency, Clinical Management System, Telehealth, Hospice), Delivery (Web - Based, On - Premises, Cloud), End User - Global Forecast to 2018
The global home healthcare software and services market is estimated to reach $6.4 billion by 2018, at a CAGR of 13.4% between 2013 and 2018. The market will be driven by skyrocketing healthcare cost, spiralling aging population that increases the incidences of chronic disorders, hospital readmission reduction program by U.S., shortage of nursing and doctors staff, OASIS documentation, and favorable government initiatives.
- Published: May 2014
- Price: $ 4950
- TOC Available:
-
Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) & Region - Global Forecast to 2025
The global clinical trial management system market growth is primed to transition from $801 million in 2020 to $1.59 billion by 2025, showcasing a strong CAGR of 14.7%. The growth of this market is driven by the increasing number of clinical trials and government support for research trials. However, budget constraints and limited knowledge about advanced CTMS solutions restrain the market's growth.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Learning Management System Market by Delivery Mode (Distance Learning, Instructor-led Learning, Blended Learning), Application Area (Corporate Training & Development, Professional Certification & Compliance, Course Management) - Global Forecast to 2028
The LMS market size is projected to reach USD 51.9 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 18.6% during the forecast period. Some of the key players operating in the learning management system market are – Anthology (US), Moodle (Australia), Cornerstone OnDemand (US), D2L Corporation (Canada), Instructure Inc. (US), PowerSchool (US), IBM (US), Infor (US), Adobe (US), LTG (UK), Google (US), Oracle (US), SAP (Germany), Docebo (Canada), Learning Pool (UK), Absorb LMS (Canada), CrossKnowledge (France), BizLibrary(US), iSpring (US), Blue Sky eLearn (US), Trakstar (US), DigitalChalk (US), Touvti LMS (US), SkyPrep (Canada), Talent LMS (US), Acorn LMS (Australia), and LearnWorlds (UK).
- Published: February 2024
- Price: $ 7150
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
